Law360, New York (May 22, 2012, 6:10 PM ET) -- Federal marshals acting on behalf of the U.S. Food and Drug Administration have seized an unapproved new corticosteroid produced by a California drugmaker after the company ignored warnings not to market the drug, the FDA said Tuesday.
Acting on a warrant signed by a California federal judge, the marshals on May 9 seized supplies of HybriSil, marketed by Vista, Calif.-based Crescendo Therapeutics LLC as a prescription topical corticosteroid gel to treat scars.
The agency didn't immediately say how much of the drug was seized.
The FDA...
FDA Seizes Drugmaker's Unapproved Topical Scar Treatment
To view the full article, take a free trial now.
